Cargando…

HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients

We aimed to characterize the different subgroups of ketosis-prone diabetes (KPD) in a sample of Tunisian patients using the Aβ scheme based on the presence or absence of β-cell autoantibodies (A+ or A−) and β-cell functional reserve (β+ or β−) and we investigated whether HLA class II alleles could c...

Descripción completa

Detalles Bibliográficos
Autores principales: Laadhar, Lilia, Harzallah, Fatma, Zitouni, Mondher, Kallel-Sellami, Maryam, Fekih, Moncef, Kaabachi, Naziha, Slimane, Hádia, Makni, Sondès
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063415/
https://www.ncbi.nlm.nih.gov/pubmed/21461382
http://dx.doi.org/10.1155/2011/964160
_version_ 1782200796163604480
author Laadhar, Lilia
Harzallah, Fatma
Zitouni, Mondher
Kallel-Sellami, Maryam
Fekih, Moncef
Kaabachi, Naziha
Slimane, Hádia
Makni, Sondès
author_facet Laadhar, Lilia
Harzallah, Fatma
Zitouni, Mondher
Kallel-Sellami, Maryam
Fekih, Moncef
Kaabachi, Naziha
Slimane, Hádia
Makni, Sondès
author_sort Laadhar, Lilia
collection PubMed
description We aimed to characterize the different subgroups of ketosis-prone diabetes (KPD) in a sample of Tunisian patients using the Aβ scheme based on the presence or absence of β-cell autoantibodies (A+ or A−) and β-cell functional reserve (β+ or β−) and we investigated whether HLA class II alleles could contribute to distinct KPD phenotypes. We enrolled 43 adult patients with a first episode of ketosis. For all patients we evaluated clinical parameters, β-cell autoimmunity, β-cell function and HLA class II alleles. Frequency distribution of the 4 subgroups was 23.3% A+β−, 23.3% A−β−, 11.6% A+β+ and 41.9% A−β+. Patients from the group A+β− were significantly younger than those from the group A−β− (P = .002). HLA susceptibility markers were significantly more frequent in patients with autoantibodies (P = .003). These patients also had resistance alleles but they were more frequent in A+β+ than A+β− patients (P = .04). Insulin requirement was not associated to the presence or the absence of HLA susceptibility markers. HLA class II alleles associated with susceptibility to autoimmune diabetes have not allowed us to further define Tunisian KPD groups. However, high prevalence of HLA resistance alleles in our patients may reflect a particular genetic background of Tunisian KPD population.
format Text
id pubmed-3063415
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30634152011-03-31 HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients Laadhar, Lilia Harzallah, Fatma Zitouni, Mondher Kallel-Sellami, Maryam Fekih, Moncef Kaabachi, Naziha Slimane, Hádia Makni, Sondès Exp Diabetes Res Clinical Study We aimed to characterize the different subgroups of ketosis-prone diabetes (KPD) in a sample of Tunisian patients using the Aβ scheme based on the presence or absence of β-cell autoantibodies (A+ or A−) and β-cell functional reserve (β+ or β−) and we investigated whether HLA class II alleles could contribute to distinct KPD phenotypes. We enrolled 43 adult patients with a first episode of ketosis. For all patients we evaluated clinical parameters, β-cell autoimmunity, β-cell function and HLA class II alleles. Frequency distribution of the 4 subgroups was 23.3% A+β−, 23.3% A−β−, 11.6% A+β+ and 41.9% A−β+. Patients from the group A+β− were significantly younger than those from the group A−β− (P = .002). HLA susceptibility markers were significantly more frequent in patients with autoantibodies (P = .003). These patients also had resistance alleles but they were more frequent in A+β+ than A+β− patients (P = .04). Insulin requirement was not associated to the presence or the absence of HLA susceptibility markers. HLA class II alleles associated with susceptibility to autoimmune diabetes have not allowed us to further define Tunisian KPD groups. However, high prevalence of HLA resistance alleles in our patients may reflect a particular genetic background of Tunisian KPD population. Hindawi Publishing Corporation 2011 2011-03-02 /pmc/articles/PMC3063415/ /pubmed/21461382 http://dx.doi.org/10.1155/2011/964160 Text en Copyright © 2011 Lilia Laadhar et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Laadhar, Lilia
Harzallah, Fatma
Zitouni, Mondher
Kallel-Sellami, Maryam
Fekih, Moncef
Kaabachi, Naziha
Slimane, Hádia
Makni, Sondès
HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title_full HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title_fullStr HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title_full_unstemmed HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title_short HLA Class II Alleles Susceptibility Markers of Type 1 Diabetes Fail to Specify Phenotypes of Ketosis-Prone Diabetes in Adult Tunisian Patients
title_sort hla class ii alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult tunisian patients
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063415/
https://www.ncbi.nlm.nih.gov/pubmed/21461382
http://dx.doi.org/10.1155/2011/964160
work_keys_str_mv AT laadharlilia hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT harzallahfatma hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT zitounimondher hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT kallelsellamimaryam hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT fekihmoncef hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT kaabachinaziha hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT slimanehadia hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients
AT maknisondes hlaclassiiallelessusceptibilitymarkersoftype1diabetesfailtospecifyphenotypesofketosispronediabetesinadulttunisianpatients